Literature DB >> 28511765

Basaglar, an Insulin 'Follow On,' Prepares To Do Battle With Lantus.

Thomas Reinke.   

Abstract

At last, there's a biosimilar-like competitor in the U.S. insulin market. Can Basaglar put some downward pressure on prices?

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28511765

Source DB:  PubMed          Journal:  Manag Care        ISSN： 1062-3388


  1 in total

1.  Emphasize Shared Decision-Making Between Physicians and Patients to Improve Diabetes Outcomes.

Authors:  Gary Branning; Stacey L Worthy; Martha Vater
Journal:  Am Health Drug Benefits       Date:  2017-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.